Filter
924
Filtered Results: 924
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
77
New Publications
285
Language
Document type
No document type
478
Studies & Reports
167
Guidelines
137
Manuals
56
Strategic & Response Plan
51
Fact sheets
14
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
39
India
32
Uganda
27
South Africa
23
Global
22
Liberia
21
Nigeria
19
Ghana
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Bangladesh
15
Malawi
15
Nepal
14
Namibia
13
Western and Central Europe
13
Zimbabwe
10
Ukraine
10
Syria
9
Cambodia
9
Myanmar / Burma
9
Philippines
8
Lesotho
8
Botswana
7
Africa
7
Eastern Europe
7
South–East Asia Region
6
Indonesia
5
Eswatini/ Swaziland
5
West and Central Africa
5
Congo, Democratic Republic of
4
East and Southern Africa
4
Western Pacific Region
4
Latin America and the Carribbean
4
Guinea
3
Burkina Faso
3
Pakistan
3
Jordan
3
Thailand
3
Benin
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Albania
3
Senegal
2
USA
2
Cameroon
2
Haiti
2
Mozambique
2
Asia
2
Laos
2
Mali
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
North Macedonia
1
Madagascar
1
Fiji
1
Timor Leste/ East Timor
1
Russia
1
Moldova
1
Iran
1
Australia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
413
Clinical Guidelines
57
Public Health
36
Key Resources
29
Pharmacy & Technologies
27
Women & Child Health
23
Capacity Building
4
Toolboxes
AMR
120
Pharmacy
117
COVID-19
53
HIV
38
TB
38
Rapid Response
34
Mental Health
32
Global Health Education
20
Planetary Health
19
Conflict
14
Caregiver
14
Ebola
13
Specific Hazards
10
NCDs
10
NTDs
9
Health Financing Toolbox
9
Polio
5
Disability
2
Natural Hazards
2
Refugee
2
Zika
2
Social Ethics
1
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the policy framework provided by the AMR policy document. ...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
WHO Secretariat Information paper July 2016
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
Two test methods on dexamethasone tablets and injections
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
The ethical governance of research assumes the existence of a national entity (or subnational if applicable, according to the constitution of a country) in charge of supervising the research ethics committees (RECs) that review and monitor research with human beings. This supervision includes the ac...
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV ...
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, community care centres, Ebola treatment centres and isolation centres. The Governments of Guinea, Liberia an...
WHO Vaccine Management Handbook
Global Action Plan on Antimicrobial Resistance
recommended
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
3rd edition
Report on assessment of WASH and healthcare waste management in District Sadar Hospital, Cox's Bazar
How safe is our hospital sanitation? An example from a public hospital
PMPB/INS-GUIDE/02
The Agency for Toxic Substances and Disease Registry (ATSDR) has produced a three-volume series entitled Managing Hazardous Material Incidents. The series is designed to help emergency response and health care professionals plan for and respond to hazardous material emergencies.
- Volume I Emergenc...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
